7,8-Dihydroneopterin
7,8-Dihydroneopterin, an inflammation marker, induces cellular apoptosis in astrocytes and neurons via enhancement of nitric oxide synthase (iNOS) expression. 7,8-Dihydroneopterin can be used in the research of neurodegenerative diseases[1].
Product Specifications
CAS Number
[1218-98-0]
UNSPSC
12352005
Hazard Statement
H315, H319, H335
Target
Apoptosis; Endogenous Metabolite; NO Synthase
Type
Natural Products
Related Pathways
Apoptosis; Immunology/Inflammation; Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/7-8-dihydroneopterin.html
Purity
99.79
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
O=C1NC(N)=NC2=C1N=C([C@H](O)[C@H](O)CO)CN2
Molecular Formula
C9H13N5O4
Molecular Weight
255.23
Precautions
H315, H319, H335
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Isoform
Human Endogenous Metabolite; iNOS
Available Sizes
Explore Other Products
Browse additional items from our catalog
Lentiviral human PCDHGA12 shRNA (UAS) - Lentiviral human PCDHGA12 shRNA (UAS) (100)
CUX2P1 sgRNA CRISPR Lentivector (Human) (Target 3)
B4GALT4, ID (B4GALT4, Beta-1,4-galactosyltransferase 4, UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 4, UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 4, N-acetyllactosamine synthase, Nal synthase, Lactotriaosylceramide beta-1,4-galactosyltransferase, Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase) (Biotin) discontinued